Efectos vasculares y moleculares de los andrógenos endógenos en un modelo experimental en conejos ateroscleróticos

Rosamond, 2007, for the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart Disease and Stroke Statistics-2007 Update. A Report From the American Heart Association Statistics Committee and Stroke Statistics Subcommittee, Circulation, 115, 1, 10.1161/CIRCULATIONAHA.106.179918 Hulley, 1998, Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women; Heart and Estrogen/progestin Replacement Study (HERS) Research Group, JAMA, 280, 605, 10.1001/jama.280.7.605 2002, Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial, JAMA, 288, 321, 10.1001/jama.288.3.321 Kalin, 1990, Sex hormones and coronary disease: a review of the clinical studies, Steroids, 55, 30, 10.1016/0039-128X(90)90058-J Yarnell, 1993, Endogenous sex hormones and ischemic heart disease in men. The Caerphilly prospective study, Arterioscler Thromb, 13, 517, 10.1161/01.ATV.13.4.517 Barrett-Connor, 1995, Prospective study of endogenous sex hormones and fatal cardiovascular disease in postmenopausal women, BMJ, 311, 1193, 10.1136/bmj.311.7014.1193 Barrett-Connor, 1995, The epidemiology of DHEAS and cardiovascular disease, Ann N Y Acad Sci, 774, 259, 10.1111/j.1749-6632.1995.tb17386.x-i1 Yarnell, 1993, Endogenous sex hormones and ischemic heart disease in men. The Caerphilly Prospective Study, Arterioscler Thromb, 13, 517, 10.1161/01.ATV.13.4.517 Marques-Vidal, 1995, Relationships of plasminogen activator inhibitor activity and lipoprotein (a) with insulin, testosterone, 17b-estradiol, and testosterone binding globulin in myocardial infarction patients and healthy controls, J Clin Endocrinol Metab, 80, 1794, 10.1210/jc.80.6.1794 Larsen, 1993, Effect of testosterone on atherogenesis in cholesterol-fed rabbits with similar plasma cholesterol levels, Atherosclerosis, 99, 79, 10.1016/0021-9150(93)90053-W Eich, 1993, Inhibition of accelerated coronary atherosclerosis with dehydroepiandrosterone in the heterotopic rabbit model of cardiac transplantation, Circulation, 8, 261, 10.1161/01.CIR.87.1.261 Bruck, 1997, Gender-specific differences in the effects of testosterone and estrogen on the development of atherosclerosis in rabbits, Arterioscler Thromb Vasc Biol, 17, 2192, 10.1161/01.ATV.17.10.2192 Adams, 1995, Effects of androgens on coronary artery atherosclerosis and atherosclerosis-related impairment of vascular responsiveness, Arterioscler Thromb Vasc Biol, 15, 562, 10.1161/01.ATV.15.5.562 Alexandersen, 1999, Natural androgens inhibit male atherosclerosis. A study in castrated, cholesterol-fed rabbits, Circ Res, 84, 813, 10.1161/01.RES.84.7.813 Alexandersen, 1996, The relationship of natural androgens to coronary heart disease in males: a review, Atherosclerosis, 125, 1, 10.1016/0021-9150(96)05864-9 Abela, 1995, Triggering of Plaque Disruption and Arterial Thrombosis in an Atherosclerotic Rabbit Model, Circulation, 91, 776, 10.1161/01.CIR.91.3.776 Huraux, 1998, A comparative evaluation of the effects of multiple vasodilators on human internal mammary artery, Anesthesiology, 88, 1654, 10.1097/00000542-199806000-00030 Gordon, 1988, Reduction of atherosclerosis by administration of dehydroepiandrosterone: a study in the hypercholesterolemic New Zealand white rabbit with aortic intimal injury, J Clin Invest, 82, 712, 10.1172/JCI113652 Uyanik, 1997, Beneficial effects of testosterone on the lipoprotein profile in healthy elderly men: a placebo controlled study, Jpn Heart J, 38, 73, 10.1536/ihj.38.73 Yarnell, 1993, Endogenous sex hormones and ischemic heart disease in men. The Caerphilly Prospective Study, Arterioscler Thromb, 13, 517, 10.1161/01.ATV.13.4.517 Phillips, 1994, The association of hypotestosteronemia with coronary artery disease in men, Arterioscler Thromb, 14, 701, 10.1161/01.ATV.14.5.701 Mitchell, 1994, Evidence for an association between dehydroepiandrosterone sulfate and non-fatal, premature myocardial infarction in males, Circulation, 89, 89, 10.1161/01.CIR.89.1.89 Herrington, 1995, Dehydroepiandrosterone and coronary atherosclerosis, Ann N Y Acad Sci, 774, 271, 10.1111/j.1749-6632.1995.tb17387.x-i1 Grady, 1992, Hormone therapy to prevent disease and prolong life in postmenopausal women, Ann Intern Med, 117, 1016, 10.7326/0003-4819-117-12-1016 Van den Beld, 2003, Endogenous hormones and carotid atherosclerosis in elderly men, Am J Epidemiol, 157, 25, 10.1093/aje/kwf160 Hak, 2002, Low levels of endogenous androgens increase the risk of atherosclerosis in elderly men: the Rotterdam study, J Clin Endocrinol Metab, 87, 3632, 10.1210/jc.87.8.3632 Alexandersen, 1996, The relationship of natural androgens to coronary heart disease in males: a review, Atherosclerosis, 125, 1, 10.1016/0021-9150(96)05864-9 Simpson, 1997, Aromatase expression in health and disease, Recent Prog Horm Res, 52, 185 Malkin, 2003, Testosterone as a protective factor against atherosclerosis—immunomodulation and influence upon plaque development and stability, J Endocrinol, 178, 373, 10.1677/joe.0.1780373 Deenadayalu, 2001, Testosterone relaxes coronary arteries by opening the large-conductance, calciumactivated potassium channel, Am J Physiol Heart Circ Physiol, 281, H1720, 10.1152/ajpheart.2001.281.4.H1720 Tep-areenan, 2002, Testosterone-induced vasorelaxation in the rat mesenteric arterial bed is mediated predominantly via potassium channels, Br J Pharmacol, 135, 735, 10.1038/sj.bjp.0704522 Yildiz, 2005, Testosterone relaxes human internal mammary artery In-Vitro, J Cardiovasc Pharmacol, 45, 580, 10.1097/01.fjc.0000161400.06704.1e Devlin, 2002, Genetic alterations of IL-1 receptor antagonist in mice affect plasma cholesterol level and foam cell lesion size, Proc Nat A Sci USA, 99, 6280, 10.1073/pnas.092324399 Tontonoz, 2003, Liver X receptor signaling pathways in cardiovascular disease, Mol Endocrinol, 17, 985, 10.1210/me.2003-0061 Joseph, 2003, LXRs: new therapeutic targets in atherosclerosis?, Current Opinion Pharmacol, 3, 192, 10.1016/S1471-4892(03)00009-2 Soumian, 2005, ABCA1 and atherosclerosis, Vasc Med, 10, 109, 10.1191/1358863x05vm593ra Liu, 2005, Androgens and cardiovascular disease, Endocrine Reviews, 24, 313, 10.1210/er.2003-0005 Heinlein, 2002, The roles of androgen receptors and androgen- binding proteins in nongenomic androgen actions, Mol Endocrinol, 16, 2181, 10.1210/me.2002-0070 Eicheler, 1995, Immunohistochemical evidence for differential distribution of 5a reductase isoenzymes in human skin, Br J Dermatol, 133, 371, 10.1111/j.1365-2133.1995.tb02663.x Harada, 1999, Localized expression of aromatase in human vascular tissues, Circ Res, 84, 1285, 10.1161/01.RES.84.11.1285 Friedl, 2000, Testosterone inhibits expression of inducible nitric oxide synthase in murine macrophages, Life Sci, 68, 417, 10.1016/S0024-3205(00)00953-X